DIVINHEALSimplifying Global Wellbeing
Home
Treatments
Hospitals
Doctors
Page background

Immunotherapy & CAR-T Cell Therapy Treatment in Bengaluru for Iraq

About

Immunotherapy & CAR-T Cell Therapy in Bengaluru for Iraq Patients

Patients from Iraq facing complex cancer diagnoses often seek advanced treatment options beyond their home country. The prospect of undergoing highly specialized procedures like Immunotherapy and CAR-T Cell Therapy can bring understandable concerns about access to cutting-edge care and finding the right medical expertise. Ensuring comprehensive, trusted care is a primary worry for many.

Many international patients, including those from Iraq, look to Bengaluru as a leading destination for specialized medical treatments. This city has emerged as a hub for advanced oncology, offering a supportive environment where state-of-the-art procedures are performed with precision and dedicated patient coordination, facilitating a smoother treatment journey.

Trust in Bengaluru's medical landscape is built upon its world-class hospitals and a strong network of highly experienced specialists. These institutions provide a seamless experience, from initial consultation to advanced treatment and essential follow-ups, all within the city’s well-integrated healthcare system. This ensures continuity and quality of care for every patient.

Is Bengaluru the right choice for your advanced cancer treatment?

What is Immunotherapy & CAR-T Cell Therapy?

Immunotherapy and CAR-T (Chimeric Antigen Receptor T-cell) Cell Therapy are revolutionary approaches in cancer treatment that harness the body's own immune system to fight cancer cells. Immunotherapy works by boosting the natural defenses of the immune system or by interfering with cancer cells' ability to hide from the immune system. CAR-T Cell Therapy is a more specialized form of immunotherapy where a patient's T-cells are genetically modified in a lab to specifically target and destroy cancer cells. These treatments offer new hope for various cancers, especially those that have not responded to traditional therapies, by providing a highly targeted and personalized attack on the disease.

Types of Immunotherapy and CAR-T Cell Therapies

Different forms of immunotherapy target specific pathways or enhance distinct aspects of the immune response:

  • Checkpoint Inhibitors: Medications that block proteins (checkpoints) that stop the immune system from attacking cancer cells.
  • Monoclonal Antibodies: Lab-produced antibodies that bind to specific targets on cancer cells or immune cells, marking them for destruction or altering their function.
  • Oncolytic Viruses: Viruses genetically modified to infect and kill cancer cells while sparing healthy tissue, also stimulating an immune response.
  • CAR-T Cell Therapy: A personalized cell therapy where T-cells are extracted, genetically re-engineered to recognize cancer antigens, multiplied, and then infused back into the patient.
  • Cytokines: Proteins that help immune cells grow and function, such as interleukins and interferons, used to stimulate an immune response against cancer.
  • Cancer Vaccines: Designed to prevent or treat cancer by stimulating the immune system to recognize and attack specific cancer cells.

When Is This Treatment Required?

  • Cancers that have not responded to standard treatments like chemotherapy or radiation.
  • Specific types of leukemia and lymphoma, particularly for CAR-T cell therapy.
  • Melanoma, lung cancer, kidney cancer, bladder cancer, and certain head and neck cancers for checkpoint inhibitors.
  • Recurrent or metastatic cancers where conventional options are exhausted.
  • Patients with a good performance status who can withstand the potential side effects of these advanced therapies.
  • When genomic testing reveals specific biomarkers that suggest responsiveness to immunotherapy agents.

Pre-Treatment Evaluation Process

  • Comprehensive medical history review and physical examination.
  • Advanced imaging studies, including PET scans, CT scans, and MRIs, to assess tumor burden and spread.
  • Biopsy and pathological review, often including molecular and genomic profiling to identify specific cancer markers.
  • Blood tests, including complete blood count, liver and kidney function tests, and viral screening.
  • Cardiac evaluation to ensure the patient's heart health is adequate for treatment.
  • Bone marrow aspiration and biopsy, especially for hematological malignancies.
  • Immunological assessments to determine baseline immune status and suitability for treatment.

How Immunotherapy & CAR-T Cell Therapy Are Performed

The specific approach for Immunotherapy or CAR-T Cell Therapy depends entirely on the type of cancer, its stage, and the patient's overall health and unique treatment plan.

For Immunotherapy (General)

  • Drug Administration: Immunotherapy drugs are typically given intravenously, often in cycles over weeks or months, as an outpatient procedure.
  • Monitoring: Patients are closely monitored for side effects, which can range from mild flu-like symptoms to more serious immune-related adverse events affecting various organs.
  • Duration: Treatment duration varies greatly, from a few months to several years, depending on the response and specific drug protocol.

For CAR-T Cell Therapy

  • Apheresis: Blood is drawn from the patient to collect their T-cells, a process similar to blood donation.
  • Cell Modification: The collected T-cells are sent to a specialized lab where they are genetically engineered to express chimeric antigen receptors (CARs) that target specific proteins on cancer cells. This process takes several weeks.
  • Chemotherapy (Lymphodepletion): Before infusion, patients often receive a short course of chemotherapy to reduce existing immune cells, making space for the CAR-T cells to expand.
  • Infusion: The modified CAR-T cells are infused back into the patient, typically as a single intravenous infusion.
  • Post-Infusion Monitoring: Patients are hospitalized for several weeks after infusion for close monitoring of side effects, which can include cytokine release syndrome (CRS) and neurological toxicities.

Recovery Process

Recovery from Immunotherapy or CAR-T Cell Therapy varies considerably depending on the specific treatment and individual response. Immunotherapy patients often manage side effects on an outpatient basis, requiring ongoing monitoring and management of immune-related adverse events. For CAR-T Cell Therapy, an initial hospital stay of several weeks is standard for intensive monitoring, followed by a period of close outpatient follow-up. Patients may experience fatigue, decreased appetite, and a weakened immune system for several months. Regular follow-up appointments, blood tests, and imaging scans are crucial to monitor recovery, manage side effects, and assess treatment efficacy. A dedicated recovery plan and potential rehabilitation support are integral parts of the healing journey.

Potential Risks and Success Rates

  • Immune system overactivity causing inflammation in healthy organs (colitis, pneumonitis, hepatitis).
  • Cytokine Release Syndrome (CRS) with CAR-T, leading to fever, low blood pressure, and difficulty breathing.
  • Neurological toxicities, such as confusion, seizures, or language difficulties, particularly with CAR-T.
  • Infections due to a weakened immune system post-treatment.
  • Fatigue, skin rashes, and endocrine disorders.
  • Infusion reactions, including chills or fever during administration.

The success rates for Immunotherapy and CAR-T Cell Therapy are highly variable, depending on the cancer type, stage, patient characteristics, and specific therapy used. For certain advanced lymphomas and leukemias, CAR-T cell therapy has achieved remission rates of 40-70% in patients who had failed previous treatments, with some experiencing long-term remissions. Immunotherapy for solid tumors, such as melanoma or lung cancer, can also lead to durable responses in a significant subset of patients. Outcomes are influenced by various factors, including the tumor's genetic profile and how the individual's immune system responds. Long-term expectations continue to evolve as more data becomes available, offering a chance for sustained disease control for many patients.

Considering Immunotherapy or CAR-T Cell Therapy?

Reach out today for personalized information and to connect with leading specialists in Bengaluru. We are here to guide your treatment journey.

Cost of Immunotherapy & CAR-T Cell Therapy in Bengaluru

The cost of Immunotherapy and CAR-T Cell Therapy in Bengaluru can vary significantly based on several factors. These include the specific type of immunotherapy drug or CAR-T product, the number of cycles required, the hospital chosen (private vs. corporate hospitals), the expertise of the treating specialist, the duration of hospital stay, and any associated pre-treatment evaluations or post-treatment supportive care.

For CAR-T Cell Therapy, the cost can range from INR 2,00,00,000 to INR 4,00,00,000. Immunotherapy treatments are typically charged per cycle, with each cycle potentially ranging from INR 2,50,000 to INR 10,00,000 or more, depending on the drug.

Bengaluru vs. Global Cost Comparison

Patients from Iraq can find that receiving advanced cancer treatment in Bengaluru offers a significant cost advantage compared to Western countries, without compromising on quality or expertise.

Treatment Bengaluru (INR) USA (USD) UK (GBP) Other Regions (USD)
CAR-T Cell Therapy 2,00,00,000 - 4,00,00,000 450,000 - 600,000 350,000 - 500,000 400,000 - 550,000
Immunotherapy (per cycle) 2,50,000 - 10,00,000 10,000 - 30,000 8,000 - 25,000 9,000 - 28,000

Comprehensive Support Services for Your Treatment Journey

  • Detailed medical opinion and treatment plan from multiple specialists.
  • Assistance with hospital appointments and admission procedures.
  • Language interpretation services for clear communication.
  • Guidance on visa application and travel logistics for patients from Iraq.
  • Arrangements for comfortable accommodation and local transport.
  • Dedicated patient coordinator to assist throughout the stay in Bengaluru.
  • Support for post-treatment follow-up and remote consultations.

Key Documents Needed for Your Medical Visit

  • Valid passport and medical visa for India.
  • All previous medical records, diagnostic reports, and physician referrals in English.
  • Summary of current health status and ongoing medications.
  • Contact information for your primary care physician back in Iraq.
  • Proof of funds or medical insurance coverage.
  • Consent forms for treatment and medical procedures.

Important Steps to Prepare Before You Arrive

  • Consult with your local doctor to gather all necessary medical documents.
  • Ensure all required vaccinations are up to date before travel.
  • Organize your travel plans and accommodation in Bengaluru in advance.
  • Familiarize yourself with the treatment process and expected timeline.
  • Discuss any dietary restrictions or specific care needs with the medical team.
  • Pack comfortable clothing and any personal items for your hospital stay.

Aftercare and Follow-Up Instructions

  • Adhere strictly to all prescribed medications and dietary advice.
  • Attend all scheduled follow-up appointments and diagnostic tests.
  • Monitor for any new symptoms or side effects and report them immediately.
  • Maintain good hygiene to prevent infections, especially if immune-compromised.
  • Gradually resume physical activities as advised by your medical team.
  • Arrange for ongoing support from your local physician upon returning to Iraq.

Ready to Explore Your Treatment Options in Bengaluru?

Our team is here to provide all the information you need and help you take the next step towards advanced cancer care.

Begin Your Path to Recovery with Confidence

Choosing Bengaluru for Immunotherapy & CAR-T Cell Therapy can offer a new path forward. Our dedicated support ensures a comprehensive and compassionate experience for every international patient.

Hospitals Offering this treatment

India offers premium medical procedures at affordable prices. Discover our most popular treatments, delivered by the country's finest doctors.

Meet Our Doctors

Meet our team of highly qualified and experienced medical professionals dedicated to providing the best healthcare services.

Dr. Shelly Mittal

Dr. Shelly Mittal

Sr. Consultant

Medical Oncology & Hematology

New Delhi

14+ Years

Experience

Artemis Hospital

Hospital

1500

Fees

View Details
Dr. Hari Goyal

Dr. Hari Goyal

Director

Medical Oncology & Haemato-Oncology

New Delhi

34+ Years

Experience

Apolo Delhi

Hospital

1500

Fees

View Details

Related Links

क्या आप अपनी चिकित्सा यात्रा शुरू करने के लिए तैयार हैं?

भारत के शीर्ष अस्पतालों से व्यक्तिगत चिकित्सा उपचार विकल्प प्राप्त करें। हमारे चिकित्सा विशेषज्ञ हर कदम पर आपकी सहायता करने के लिए तैयार हैं।